Medacta Group S.A.
MEDGF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $344 | $302 | $289 | $256 |
| % Growth | 14% | 4.6% | 12.9% | – |
| Cost of Goods Sold | $109 | $100 | $91 | $84 |
| Gross Profit | $235 | $202 | $198 | $172 |
| % Margin | 68.3% | 66.8% | 68.5% | 67.3% |
| R&D Expenses | $12 | $11 | $10 | $11 |
| G&A Expenses | $45 | $39 | $37 | $32 |
| SG&A Expenses | $163 | $144 | $142 | $129 |
| Sales & Mktg Exp. | $118 | $105 | $106 | $97 |
| Other Operating Expenses | -$14 | $15 | $2 | $1 |
| Operating Expenses | $161 | $170 | $155 | $140 |
| Operating Income | $74 | $32 | $43 | $31 |
| % Margin | 21.5% | 10.5% | 14.8% | 12.3% |
| Other Income/Exp. Net | -$5 | $12 | $2 | -$9 |
| Pre-Tax Income | $69 | $43 | $45 | $23 |
| Tax Expense | $9 | $8 | $7 | $4 |
| Net Income | $60 | $35 | $38 | $18 |
| % Margin | 17.4% | 11.6% | 13.2% | 7.1% |
| EPS | 3.01 | 1.76 | 1.9 | 0.91 |
| % Growth | 71% | -7.4% | 108.8% | – |
| EPS Diluted | 3.01 | 1.76 | 1.9 | 0.91 |
| Weighted Avg Shares Out | 20 | 20 | 20 | 20 |
| Weighted Avg Shares Out Dil | 20 | 20 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $5 | $9 | $0 | $0 |
| Depreciation & Amortization | $36 | $17 | $32 | $15 |
| EBITDA | $97 | $65 | $78 | $48 |
| % Margin | 28.2% | 21.4% | 26.9% | 18.9% |